Action for child survival: Elimination of Haemophilus influenzae type b meningitis in Uganda

Bulletin of the World Health Organization

Volumn 86, Issue 4, 2008, Pages 292-301

  Lewis, Rosamund F ^a   Kisakye, Annet ^b   Gessner, Bradford D ^c   Duku, Chaplain ^d   Odipio, John Bosco ^d   Iriso, Robert ^e   Nansera, Denis ^f   Braka, Fiona ^a   Makumbi, Issa ^b   Kekitiinwa, Addy ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MINISTRY OF HEALTH   (Uganda)

^c Agence de Medecine Preventive   (France)

^d MULAGO NATIONAL REFERRAL HOSPITAL   (Uganda)

^e St Mary's Hospital Lacor Uganda   (Uganda)

^f Mbarara University Teaching Hospital   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE;

CHILD HEALTH; DISEASE INCIDENCE; DISEASE PREVALENCE; IMMUNIZATION; INFLUENZA; PUBLIC HEALTH; SURVIVAL; VACCINE;

ARTICLE; BACTERIAL MENINGITIS; CHILD HEALTH; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRESCHOOL CHILD; SURVIVAL; UGANDA;

BACTERIAL CAPSULES; CHILD, PRESCHOOL; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MENINGITIS, HAEMOPHILUS; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE; UGANDA;

AFRICA; EAST AFRICA; SUB-SAHARAN AFRICA; UGANDA;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 42049096739     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.07.045336     Document Type: Article

References (39)

1. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec World Health Organization 2006;81:445-52.
2. Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatality rates. Geneva: WHO; 2002 (WHO/V&B/02.18).
3. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005;366:144-50. PMID:16005337 doi:10.1016/S0140-6736(05)66788-8
4. Daza P, Banda R, Misoya K, Katsulukuta A, Gessner BD, Katsande R, et al. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 2006;24:6232-9. PMID:16806603 doi:10.1016/j.vaccine.2006.05.076
5. Cowgill KD, Ndiritu M, Nyiro J, Slack MPE, Chiphatsi S, Ismail A, et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006;296:671-8. PMID:16896110 doi:10.1001/jama.296.6.671
6. Feikin DR, Nelson CB, Watt JP, Mohsni E, Wenger JD, Levine OS. Rapid assessment tool for Haemophilus influenzae type b disease in developing countries. Emerg Infect Dis 2004;10:1270-6.
7. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus-Influenzae type-B (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6. PMID:8417239 doi:10.1001/jama.269. 2.221
8. Wenger JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatr Infect Dis J 1998;17:S132-6. PMID:9781746 doi:10.1097/00006454-199809001-00008
9. Moore DL, Vaudry W, Scheifele DW, Halperin SA, Déry P, Ford-Jones E, et al. Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003. CMAJ 2005;172:53-6.
10. Gessner BD, Sutanto A, Linehan M, Djelantik IG, Fletcher T, Gerudug IK, et al. The incidence of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children using a hamlet-randomized vaccine probe design. Lancet 2005;365:43-52. PMID:15643700 doi:10.1016/S0140-6736(04)17664-2
11. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, et al. Randomized trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349:1191-7. PMID:9130939 doi:10.1016/S0140-6736(96)09267-7
12. Standards for surveillance of selected vaccine-preventable diseases. Geneva: WHO. Available from: http://www.who.int/ immunization_monitoring/diseases/meningitis_surveillance/en/index.html [accessed 5 February 2008].
13. Uganda 2002 population and housing census main report. Entebbe: Uganda Bureau of Statistics; 2002 Available from: http://www.ubos.org/ 2002%20Census%20Final%20Reportdoc.pdf [accessed 5 February 2008].
14. Uganda demographic and health survey 2000-2001 key findings. Entebbe: Uganda Bureau of Statistics and ORC Macro. Available from: http://www.measuredhs.com/pubs/pdf/SR91/UgandaKF.pdf [accessed 5 February 2008].
15. Uganda demographic and health survey 2006. Entebbe: Uganda Bureau of Statistics and ORC Macro; 2007. Available from: http://www.measuredhs.com/ pubs/pdf/FR194/FR194.pdf [accessed 5 February 2008].
16. Uganda country profile. GAVI Alliance; 2004. Available from: http://www.gavialliance.org/resources/cp_2004_uganda.pdf [accessed on 5 February 2008].
17. Uganda reported immunization coverage. Geneva: WHO; 2007. Available from: http://www.who.int/immunization_monitoring/en/globalsummary/ timeseries/tscoveragebycountry.cfm?country=Uganda [accessed on 5 February 2008].
18. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals [approved standard]. 2nd ed. Wayne, PA: Clinical Laboratory Standards Institute; 2002.
19. The state of the world's children 2007. New York, NY: UNICEF. Available from: http://www.unicef.org/publications/files/ The_State_of_the_Worlds_Children_2007_e.pdf [accessed 5 February 2008].
20. Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002;360:211-8. PMID:12133656 doi:10.1016/S0140-6736(02)09458-8
21. Sutanto A, Gessner BD, Djlantik IGG, Steinhoff M, Murphy H, Nelson C, et al. Acute respiratory illness incidence and death among children under two years of age on Lombok Island, Indonesia. Am J Trop Med Hyg 2002;66:175-9.
22. World Health Organization. Progress in global measles control and mortality reduction, 2000-2006. Wkly Epidemiol Rec 2007;82:418-24.
23. Nanyunja M, Lewis RF, Makumbi I, Seruyange R, Kabwongera E, Mugyenyi P, et al. Impact of mass measles campaigns in children less than five years old in Uganda. J Infect Dis 2003;187 Suppl 1;S63-8. PMID:12721893 doi:10.1086/368026
24. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS and the Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet 2003;362:65-71. PMID:12853204 doi:10.1016/S0140-6736(03)13811-1
25. Lee E, Lewis RF, Makumbi I, Kekitiinwa A, Ediamu T, Bazibu M, et al. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study. Trop Med Int Health 2008. Epublished ahead of print. doi:10.1111/j.1365-3156.2008.02027.x
26. Garner D, Weston V. Effectiveness of vaccination for Haemophilus influenzae type b. Lancet 2003;361:395-6. PMID:12573380 doi:10.1016/S0140-6736(03)12385-9
27. Pushparajah K, Ramnarayan P, Maniyar A, Paget R, Britto J. Continued threat of Haemophilus inflenzae type b disease in the UK. Lancet 2003;361:90. PMID:12517517 doi:10.1016/S0140-6736(03)12159-9
28. Kisakye A, Makumbi I, Nansera D, Lewis RF, Braka F, Wobudeya E, et al. Surveillance for Streptococcus pneumoniae meningitis in children under 5 years of age: implications for immunization in Uganda. Clin Infect Dis 2008; suppl. In press.
29. Ribeiro GS, Reis JN, Cordeiro SM, Lima JB, Gouveia EL, Petersen M, et al. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 2003;187:109-16. PMID:12508153 doi:10.1086/345863
30. Madhi SA, Petersen K, Khoosal M, Huebner RE, Mbelle N, Mothupi R, et al. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 2002;21:315-21. PMID:12075763 doi:10.1097/00006454-200204000-00011
31. Uganda HIV/AIDS sero-behavioural survey 2004-2005. Calverton, MD: Ministry of Health [Uganda] and ORC Macro; 2006. pp. 114-116.
32. Centres for Disease Control. Serotyping discrepancies in Haemophilus influenzae type b disease - United States, 1998-1999. MMWR Morb Mortal Wkly Rep 2002;51:706-7.
33. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 2007;82:93-104.
34. Baqui AH, El Arifeen S, Saha SK, Persson L, Zaman K, Gessner BD, et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Pediatr Infect Dis J 2007;26:565-71. PMID:17596795 doi:10.1097/INF.0b013e31806166a0
35. Mugyenyi P, Braka F, Makumbi I, Kabwongera E, Seruyange R, Zaninka P, et al. Uganda routine immunization performance improvement initiatives. Task Force on Immunization in Africa 13th Annual Meeting, Brazzaville, Congo, 28 Feb - 3 March 2006. Available from: http://www.afro.who.int/ddc/vpd/tfi2006/ reports/tfi_report_2005_english.pdf [accessed on 5 February 2008].
36. Lewis R, Zaffran M, Melgaard B. Immunization. In: International Encyclopedia of Public Health. Elsevier. In press. Available from: http://www1.elsevier.com/homepage/about/mrwd/pubh/ [accessed 28 February 2008].
37. Akumu AO, English M, Scott JAG, Griffiths UK. Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. Bull World Health Organ 2007;85:511-8.
38. Karamagi H, Lewis R. Costs and outcomes relating to hepatitis B and Haemophilus influenzae type b vaccine policy options: a Uganda case study. Social Science Research Network, 2006. Available from: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=994145 [accessed 5 February 2008].
39. Knowledge into action for child survival. The Bellagio Study Group on Child Survival. Lancet 2003;362:323-7. PMID:12892965 doi:10.1016/S0140- 6736(03)13977-3